![]() |
Open for inclusion |
Phase II Study of Carfilzomib-cyclophosphamide-dexamethasone and High-dose Melphalan (HDT) Followed by Randomization Between Observation or Maintenance With Carfilzomib and Dexamethasone in Patients With Relapsed Multiple Myeloma After HDTCancer type: Myeloma Phase: II Principal Investigator: Schjesvold Fredrik Country: NO Keywords: Norway, Oslo Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02572492 |